Mangalam Drug Chem Share Price
Mangalam Drug Chem Share Price Today
As of 5 Jul 2026, Mangalam Drug Chem share price is ₹28.09. The stock opened at ₹28.25, compared to its previous close of ₹28.25. During today's trading session, Mangalam Drug Chem share price moved in the range of ₹27.61 to ₹29.30, with an average price of ₹28.45 for the day. Looking at its last 52-week, the stock has touched a low of ₹22.80 and a high of ₹95.00. On the performance front, Mangalam Drug Chem share price has declined by 7.35% over the last six months and is down 66.34% on a year-on-year basis.
Mangalam Drug Chem Returns Calculator
Mangalam Drug Chem Shareholder Returns
Mangalam Drug Chem Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
Mangalam Drug Chem Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 |
|---|---|---|
| Revenue | ₹318.23 | ₹368.59 |
| Other Income | ₹0.50 | ₹0.10 |
| Total Revenue | ₹318.73 | ₹368.69 |
| Total Expenses | ₹313.95 | ₹379.77 |
| Profit Before Tax | ₹4.79 | -₹11.07 |
| Tax | -₹1.93 | -₹2.00 |
| Profit After Tax | ₹6.72 | -₹9.07 |
| EPS - Basic | ₹4.25 | -₹5.73 |
| EPS - Diluted | ₹4.25 | -₹5.73 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 |
|---|---|---|
| Profit before tax | ₹4.79 | ₹3.97 |
| Income before WC changes | ₹35.38 | ₹17.92 |
| Change in Assets | -₹21.30 | ₹29.86 |
| Change in Liabilities | ₹28.59 | -₹43.77 |
| Change in WC | ₹7.29 | -₹13.91 |
| Cash flow from Operations | ₹42.59 | ₹3.91 |
| Cash flow from Investing | -₹19.47 | -₹11.83 |
| Cash flow from Financing | -₹21.71 | ₹5.23 |
| Total Cash Flow | ₹1.41 | -₹2.69 |
| Cash (Start of the year) | ₹1.18 | ₹3.87 |
| Cash (End of the year) | ₹2.59 | ₹1.18 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 |
|---|---|---|
| Non-Current Assets | ₹167.44 | ₹157.70 |
| Current Assets | ₹198.98 | ₹176.00 |
| Total Assets | ₹366.42 | ₹333.70 |
| Current Liabilities | ₹191.60 | ₹164.06 |
| Net Current Asset | ₹7.38 | ₹11.94 |
| Non-Current Liabilities | ₹25.84 | ₹33.85 |
| Equity Capital | ₹148.98 | ₹135.79 |
| Total Equity & Liabilities | ₹366.42 | ₹333.70 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹318.23 | ₹368.59 | ₹372.25 | ₹451.07 |
| Other Income | ₹0.50 | ₹0.10 | ₹0.44 | ₹0.09 |
| Total Revenue | ₹318.73 | ₹368.69 | ₹372.69 | ₹451.16 |
| Total Expenses | ₹313.74 | ₹379.75 | ₹370.47 | ₹423.42 |
| Profit Before Tax | ₹4.99 | -₹11.06 | ₹2.21 | ₹27.73 |
| Tax | -₹1.93 | -₹2.01 | ₹0.94 | ₹8.08 |
| Profit After Tax | ₹6.92 | -₹9.05 | ₹1.27 | ₹19.66 |
| EPS - Basic | ₹4.37 | -₹5.72 | ₹0.80 | ₹12.42 |
| EPS - Diluted | ₹4.37 | -₹5.72 | ₹0.80 | ₹12.42 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹4.99 | -₹11.06 | ₹2.21 | ₹27.73 |
| Income before WC changes | ₹35.36 | ₹16.75 | ₹26.34 | ₹50.11 |
| Change in Assets | ₹2.64 | ₹4.02 | -₹19.29 | -₹46.67 |
| Change in Liabilities | ₹4.84 | -₹8.42 | ₹31.01 | ₹31.08 |
| Change in WC | ₹7.49 | -₹4.39 | ₹11.72 | -₹15.59 |
| Cash flow from Operations | ₹42.76 | ₹12.17 | ₹38.08 | ₹25.71 |
| Cash flow from Investing | -₹19.47 | -₹17.90 | -₹22.17 | -₹27.33 |
| Cash flow from Financing | -₹21.71 | ₹5.70 | -₹16.82 | ₹2.98 |
| Total Cash Flow | ₹1.57 | -₹0.04 | -₹0.91 | ₹1.36 |
| Cash (Start of the year) | ₹1.00 | ₹1.04 | ₹1.95 | ₹0.58 |
| Cash (End of the year) | ₹2.57 | ₹1.00 | ₹1.04 | ₹1.95 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹160.25 | ₹157.36 | ₹154.72 | ₹143.39 |
| Current Assets | ₹198.99 | ₹199.78 | ₹203.26 | ₹185.03 |
| Total Assets | ₹359.24 | ₹357.14 | ₹357.98 | ₹328.43 |
| Current Liabilities | ₹184.74 | ₹180.95 | ₹163.71 | ₹130.11 |
| Net Current Asset | ₹14.25 | ₹18.83 | ₹39.55 | ₹54.92 |
| Non-Current Liabilities | ₹25.84 | ₹33.85 | ₹42.32 | ₹47.75 |
| Equity Capital | ₹148.66 | ₹142.35 | ₹151.96 | ₹150.56 |
| Total Equity & Liabilities | ₹359.24 | ₹357.14 | ₹357.98 | ₹328.43 |
About Mangalam Drug Chem
Mangalam Drugs and Organics Limited is an India-based manufacturer of active pharmaceutical ingredients (APIs) and intermediates. Under the Company's Fight Malaria Program, it supplies anti-malaria APIs worldwide. Its products include API, intermediates and specialty chemicals. Its API products include acyclovir, amodiaquine, artemether, artesunate, atazanavir sulfate, bisoprolol fumarate, chloroquine phosphate, furosemide and dolutegravir sodium. The Company's intermediates products include 4,6-Dichloro-5-Methoxy Pyrimidine; 4,7- dichloroquinoline; ortho phenoxy methane sulfonanilide; tenofovir alafenamide base, and tenofovir disoproxil base. Its specialty chemical products include L (+)-menthol; 2,3-dihydrophthalazine-1,4-dione or phthalazine-1,4-dione, and 4-cynoethyl-2-methyl phenol. Its pipeline APIs (under development) include Ganaplacide (IH), Tafenoquine Succinate (IH) and Pretomanid (IH). Its pipeline APIs (developed for research and development) is Bictegravir Na (IH).
Mangalam Drug Chem Financial Highlights
- Revenue: Mangalam Drug Chem reported revenue of ₹232.89 crore in FY26 vs ₹318.74 crore in FY25. It showed a decrease of 26.93% on a yearly basis.
- Operating Profit: Mangalam Drug Chem reported an operating loss of ₹48.57 crore in FY26 vs ₹4.79 crore in FY25. It showed a decrease of 1,113.99% on a year-on-year basis.
- Net Profit: Mangalam Drug Chem reported a net loss of ₹44.40 crore in FY26 vs ₹6.72 crore in FY25. It showed a decrease of 760.71% on a yearly basis.
Mangalam Drug Chem Quarterly Result Highlights
- Mangalam Drug Chem reported revenue of ₹67.38 crore in Mar 2026, compared with ₹58.60 crore in Dec 2025, representing an increase of 14.98% on a quarter-on-quarter (QoQ) basis.
- Mangalam Drug Chem reported an operating loss of ₹13.27 crore in Mar 2026, compared with ₹9.84 crore in Dec 2025, representing a decrease of 34.86% on a quarter-on-quarter (QoQ) basis.
- Mangalam Drug Chem reported a loss of ₹13.42 crore in Mar 2026, compared with ₹9.84 crore in Dec 2025, reflecting a decrease of 36.38% on a QoQ basis.
- The earnings per share (EPS) of Mangalam Drug Chem stood at ₹4.25 during Mar 2026.
Similar Stocks
FAQs on Mangalam Drug Chem Share Price
What is Mangalam Drug Chem share price today?
Mangalam Drug Chem share price is ₹28.09 as on 03 Jul, 2026, 15:44 IST.
How has the Mangalam Drug Chem share price performed in the past?
In the last 1 year, Mangalam Drug Chem delivered a return of -66.34%. The Mangalam Drug Chem share price hit a high of ₹95.00 and low of ₹22.80.
How much is the Mutual Fund shareholding in Mangalam Drug Chem shares?
The Mutual Fund Shareholding in Mangalam Drug Chem was 0.00% at the end of Mar 2026.
What is the the 52-week high and low of Mangalam Drug Chem shares ?
The 52-week high and low of Mangalam Drug Chem share is ₹95.00 and ₹22.80 as of 03 Jul, 2026.
What is the market cap of Mangalam Drug Chem?
The market capitalisation of Mangalam Drug Chem is ₹44.64 Crores as on 03 Jul, 2026.
What are the stock symbols of Mangalam Drug Chem?
The stock symbol of Mangalam Drug Chem is MANGALAM on the NSE, 532637 on the BSE, and the ISIN is INE584F01014.
What was yesterday's closing price of Mangalam Drug Chem shares ?
Mangalam Drug Chem shares closed yesterday at ₹28.25 on NSE & ₹28.20 on BSE
How to buy Mangalam Drug Chem shares?
To buy Mangalam Drug Chem shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy Mangalam Drug Chem shares on Holidays?
No, shares of Mangalam Drug Chem or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Mangalam Drug Chem shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of Mangalam Drug Chem?
The PE and PB ratio of Mangalam Drug Chem is -1.01 and 0.47 respectively, as on 03 Jul, 2026, 15:44 IST.